$VRTX Company News Oracle falls on earnings, Ellison

New Post Public Reply Private Reply Replies (0) Message Board

Sep 21, 2014 at 10:41 AM

$VRTX Company News

Oracle falls on earnings, Ellison move; Alibaba soars on debut 4:08 p.m. Sept. 19, 2014 - Sue Chang
Vertex Pharmaceuticals shares jump 4.9%, pace S&P 500 advancers 9:59 a.m. Sept. 5, 2014 - Tomi Kilgore
U.S. stocks push higher; biotechs rally 4:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Vertex leads S&P 500, King drops on outlook 3:55 p.m. Aug. 13, 2014 - Sue Chang
10 stocks suffering the biggest cuts in earnings estimates 1:39 p.m. Aug. 11, 2014 - Philip van Doorn
Kinder Morgan soars, Tesla rallies on upgrade 12:46 p.m. Aug. 11, 2014 - Sue Chang
Mobileye rises for second day; Michael Kors falls 1:23 p.m. Aug. 4, 2014 - Sue Chang
Charting a slow-motion breakout attempt 11:08 a.m. July 23, 2014 - Michael Ashbaugh
U.S. stocks fall; Dow in triple-digit loss 4:36 p.m. June 24, 2014 - Anora Mahmudova
Dow falls over 100 points; energy stocks sell off: Stock market live blog recap 3:46 p.m. June 24, 2014 - blogs.marketwatch.com
Vertex soars on trial success; Best Buy gets buy rating 3:30 p.m. June 24, 2014 - Sue Chang
New studies bode well for Vertex's cystic fibrosis drug, analysts say 1:32 p.m. June 24, 2014 - Russ Britt
Vertex Pharmaceuticals shares skyrocket 50% 9:33 a.m. June 24, 2014 - Sue Chang
Vertex’ late-stage Cystic Fibrosis trial meets goals 7:59 a.m. June 24, 2014 - Anna Prior
Vertex Pharmaceuticals soars 46% on treatment trial 7:32 a.m. June 24, 2014 - Ben Eisen
Vertex reports successful Phase 3 trial of cystic fibrosis treatment 7:23 a.m. June 24, 2014 - Ciara Linnane
Vertex reports successl Phase 3 trial of cystic fibrosis treatment 7:12 a.m. June 24, 2014 - Ciara Linnane
E-Trade, Schwab up on HFT hearing; Tesla extends gains 3:54 p.m. June 17, 2014 - Sue Chang
Covidien surges on sale; Yahoo drops on Alibaba results 3:48 p.m. June 16, 2014 - Sue Chang
Charting the approach of S&P 2,000 12:28 p.m. June 10, 2014 - Michael Ashbaugh

Biggest Movers in Healthcare Stocks Now – ANAC CLDX VRTX EXAS 7:45 a.m. Sept. 19, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – VRTX IRWD NBIX ACOR 1:15 p.m. Sept. 18, 2014 - InvestorPlace.com
Stock Market News for September 16, 2014 - Market News 10:10 a.m. Sept. 16, 2014 - Zacks.com
3 Hot Ways to Play the Biotechnology Bonanza 6:36 a.m. Sept. 16, 2014 - InvestorPlace.com
Uncertainty Prevails For Vertex 3:48 p.m. Sept. 11, 2014 - Seeking Alpha
3 Stocks Underperforming Today In The Health Care Sector 1:04 p.m. Sept. 9, 2014 - TheStreet.com
Stock Market News for September 08, 2014 - Market News 10:10 a.m. Sept. 8, 2014 - Zacks.com
Goldman Sachs Upgrades Vertex Pharmaceuticals To Buy 6:59 a.m. Sept. 8, 2014 - benzinga.com
Vertex Pharmaceuticals (VRTX) Is Today's Strong On High Volume Stock 10:01 a.m. Sept. 5, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – VRTX HCA BLUE CYH 8:30 a.m. Sept. 5, 2014 - InvestorPlace.com
Analysts' Actions: Ciena, Finisar, Vertex and More 8:16 a.m. Sept. 5, 2014 - TheStreet.com
Top Analyst Upgrades and Downgrades: BP, Ciena, Finisar, SanDisk, VeriFone, Vertex, Wynn and More 7:37 a.m. Sept. 5, 2014 - 247WallSt.com
Stock Market News for August 26, 2014 - Market News 10:10 a.m. Aug. 26, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – PBYI TRNX KERX NBIX 1:15 p.m. Aug. 22, 2014 - InvestorPlace.com
3 Drugs Stocks Dragging The Industry Down 1:04 p.m. Aug. 21, 2014 - TheStreet.com
Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog 11:08 a.m. Aug. 20, 2014 - Zacks.com
Biotech, Social Media Stocks Are Less Frothy Than Janet Yellen Thinks 12:34 p.m. Aug. 14, 2014 - TheStreet.com
Stock Market News for August 14, 2014 - Market News 10:10 a.m. Aug. 14, 2014 - Zacks.com
Stock Market Today: Equities Rally Despite Poor Retail Earnings - Stocks in the News 4:44 p.m. Aug. 13, 2014 - Zacks.com
Hottest Healthcare Stocks Now – VRTX LCI ENDP CBPO 8:15 a.m. Aug. 13, 2014 - InvestorPlace.com

Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 9:15 a.m. Sept. 11, 2014 - PR Newswire - PRF
Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 9:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 9:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014 9:03 a.m. Sept. 8, 2014 - BusinessWire - BZX
Vertex to Present at the Morgan Stanley Global Healthcare Conference on September 10 4:01 p.m. Sept. 2, 2014 - BusinessWire - BZX
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 8:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 9:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment 2:44 p.m. Aug. 11, 2014 - ACCESSWIRE
New Joint Ventures, Course Launches, Study Results, Earnings Performance, and Approvals - Research Reports on Johnson Controls, Intuitive Surgical, GlaxoSmithKline, Community Health and Vertex 8:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma 8:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
Vertex Receives European Approval for KALYDECO™ (ivacaftor) in Eight Non-G551D Gating Mutations 4:18 p.m. July 31, 2014 - BusinessWire - BZX
MONDAY DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 -- VRTX 6:56 p.m. July 25, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 In Vertex Pharmaceuticals Incorporated To Contact The Firm Before The Lead Plaintiff Deadline In Class Action Lawsuit -- VRTX 5:44 p.m. July 22, 2014 - GlobeNewswire
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 -- VRTX 1:33 p.m. July 15, 2014 - GlobeNewswire
Vertex to Announce Second Quarter 2014 Financial Results on July 29 4:01 p.m. July 14, 2014 - BusinessWire - BZX
Vertex Announces Retirement of Peter Mueller, Ph.D. 8:02 a.m. July 10, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action against Vertex Pharmaceuticals Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of July 28, 2014 6:11 p.m. July 7, 2014 - BusinessWire - BZX
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for Use of KALYDECO® (ivacaftor) in People 18 and Older with Cystic Fibrosis who have the R117H Mutation 4:05 p.m. June 30, 2014 - BusinessWire - BZX
Scheduled Conference Calls, License Agreements, Dividends, Preliminary Proxy statements and Initiation of Clinical Studies - Analyst Notes on Merck, Johnson & Johnson, AbbVie, Valeant and GSK 5:20 a.m. June 30, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

PZZA Faces Class Action: Strategic Shake-up or Misstep?

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

Pathalys' Phase 3 Data Shows Promise for CKD Drug

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

DigitalXForce Booms with 514% Growth and Major Backing

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...